AR104157A1 - COMPOSITIONS AND METHODS FOR THE TREATMENT OF THE ANEMIA - Google Patents
COMPOSITIONS AND METHODS FOR THE TREATMENT OF THE ANEMIAInfo
- Publication number
- AR104157A1 AR104157A1 ARP160100872A ARP160100872A AR104157A1 AR 104157 A1 AR104157 A1 AR 104157A1 AR P160100872 A ARP160100872 A AR P160100872A AR P160100872 A ARP160100872 A AR P160100872A AR 104157 A1 AR104157 A1 AR 104157A1
- Authority
- AR
- Argentina
- Prior art keywords
- anemia
- treatment
- compositions
- methods
- kidney disease
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Dosis específicas de, y regímenes de dosificación para, por el uso de un inhibidor de prolil hidroxilasa de HIF en el tratamiento o la prevención de la anemia, tal como la anemia secundaria a o asociada con la enfermedad renal crónica, la anemia secundaria a o asociada con la enfermedad renal crónica no dependiente de diálisis, la anemia asociada con o que resulta de la quimioterapia o la anemia asociada con el SIDA.Specific doses of, and dosage regimens for, by the use of a HIF prolyl hydroxylase inhibitor in the treatment or prevention of anemia, such as anemia secondary to or associated with chronic kidney disease, anemia secondary to or associated with chronic kidney disease not dependent on dialysis, anemia associated with or resulting from chemotherapy or anemia associated with AIDS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562141420P | 2015-04-01 | 2015-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR104157A1 true AR104157A1 (en) | 2017-06-28 |
Family
ID=59256469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160100872A AR104157A1 (en) | 2015-04-01 | 2016-03-31 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF THE ANEMIA |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR104157A1 (en) |
-
2016
- 2016-03-31 AR ARP160100872A patent/AR104157A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017011200A2 (en) | Compositions and methods for the treatment of anemia | |
| ECSP20058592A (en) | COMPOSITIONS AND METHODS TO TREAT ANEMIA | |
| CL2015002891A1 (en) | Deaza-macrocyclic purinones for the treatment of viral infections. | |
| EA201692285A8 (en) | EZH2 INHIBITORS FOR TREATING LYMPHOMA | |
| CL2015001377A1 (en) | Inhibitors of bmi-1 reverse substituted primidins | |
| EA201692204A1 (en) | COMPOSITIONS AND METHODS OF MODULATING THE EXPRESSION OF COMPLEX B FACTOR | |
| CL2016002835A1 (en) | "Compounds derived from pladienolide with a pyridinic moiety; pharmaceutical composition comprising them; and its use in cancer treatment. ” pct | |
| PH12019501018A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
| CL2016003074A1 (en) | Compounds derived from 2-oxy-2-phenyl-n-5-pyrrolidin-3-ylamino-1,3,4-thiadiazol-2-ylacetamide, pharmaceutical composition gls1 inhibitors and their use to treat cancer. | |
| BR112017002675A2 (en) | methods for improving myocardial performance in fontan patients using udenafil compositions | |
| BR112017009854A2 (en) | compound, use of a compound, and method for treating leukemia. | |
| BR112018013847A2 (en) | methods for administering angiotensin ii | |
| CL2015002069A1 (en) | Methods for the use of phenoxypropylamine compounds to treat depression. | |
| AR104157A1 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF THE ANEMIA | |
| GB2543709A (en) | Pharmaceutical agent | |
| CR20150660A (en) | COMPOSITIONS AND METHODS TO TREAT ANEMIA | |
| BR112018070526A2 (en) | Renal cell carcinoma treatment with lenvatinib and everolimus |